Lung Cancer
Recommended
Price: Low to High
Price: High to Low
Newest
Best Selling
TASSO (Osimertinib) 80mg*30 | Julphar Bangladesh Generic | GLT
Jenphar Bangladesh (Julphar group) — osimertinib 80mg generic for EGFR-mutant NSCLC
Osikin (Osimertinib) 80mg*10/30 | Ziska Bangladesh Generic | GLT
Ziska Pharmaceuticals Bangladesh — osimertinib 80mg generic in 10 and 30 tablet packs
Xin'ao (Osimertinib) 40mg/80mg*30 | Hansoh China Generic | GLT
Jiangsu Hansoh — bioequivalent osimertinib generic in 40mg and 80mg strengths
Qilu (Osimertinib) 80mg*30 | Qilu China Generic | GLT
Qilu Pharmaceutical (Hainan) — bioequivalent osimertinib 80mg generic for NSCLC
Lorlatinib (PHOLORLA) 25mg & 100mg Tablets | ALK/ROS1 Inhibitor Generic | GLT
Generic lorlatinib for ALK-positive NSCLC, including brain metastases.
Lorlatinib (Lorbrena) 100mg Tablets | US FDA-Approved ALK Inhibitor for NSCLC | GLT
Pfizer's third-generation brain-penetrant ALK/ROS1 inhibitor for ALK-positive metastatic NSCLC.
Lorlatinib (Lorbrena) 25mg & 100mg Tablets | China NMPA-Approved ALK Inhibitor for NSCLC | GLT
Pfizer's third-generation brain-penetrant ALK/ROS1 inhibitor for ALK-positive NSCLC, including brain metastases.
Lorlatinib (Lorbrexen) 100mg Tablets | ALK/ROS1 Inhibitor Generic | GLT
Generic lorlatinib for ALK-positive NSCLC, including brain metastases.
Lorlatinib (LuciLorla) 25mg & 100mg Tablets | ALK/ROS1 Inhibitor Generic | GLT
Generic lorlatinib for ALK-positive NSCLC, including brain metastases.
Lorlatinib (Lorlatini) 25mg & 100mg Tablets | ALK/ROS1 Inhibitor Generic | GLT
Generic lorlatinib for ALK-positive NSCLC, including brain metastases.
Lorlatinib (Lornatib) 100mg Tablets | ALK/ROS1 Inhibitor Generic | GLT
Generic lorlatinib for ALK-positive NSCLC, including brain metastases.
Lorlatinib (Lorladx) 25mg & 100mg Tablets | ALK/ROS1 Inhibitor Generic | GLT
Generic lorlatinib for ALK-positive NSCLC, including brain metastases.
Ceritinib (Cerinib) 150mg*30's | DIL Bangladesh Generic | GLT
Cerinib — Drug International (DIL) Bangladesh generic ceritinib 150mg, 30-capsule pack for ALK-positive NSCLC.
Ceritinib (Cerini) 150mg*50's | TLPH Laos Generic | GLT
Cerini — Trans Continental (TLPH) Laos generic ceritinib 150mg, 50-capsule pack for ALK-positive NSCLC.
Rozlytrek (Entrectinib) 200mg Capsules | Hong Kong-Sourced NTRK/ROS1 Inhibitor | GLT
Roche (Hong Kong) original-brand entrectinib for ROS1-positive NSCLC and NTRK fusion-positive solid tumors — Hong...
Ceritinib (LuciCer) 150mg*50's | Lucius Laos Generic | GLT
LuciCer — Lucius Pharmaceuticals Laos generic ceritinib 150mg, 50-capsule pack for ALK-positive NSCLC.
LuciEntre (Entrectinib) Capsules | NTRK/ROS1 Inhibitor Generic | GLT
LuciEntre (Lucius Pharmaceuticals (Lao)) — entrectinib generic for ROS1-positive NSCLC and NTRK fusion-positive solid tumors.
Rozlytrek (Entrectinib) 200mg Capsules | South Korea-Sourced NTRK/ROS1 Inhibitor | GLT
Roche Korea original entrectinib — FDA-approved NTRK/ROS1 inhibitor for ROS1-positive NSCLC and NTRK fusion-positive solid...
Aentrek (Entrectinib) Capsules | NTRK/ROS1 Inhibitor Generic | GLT
Aentrek (Trans Continental Life Science & Pharmaceuticals (TLPH)) — entrectinib generic for ROS1-positive NSCLC and...
Rozlytrek (Entrectinib) 200mg Capsules | China NMPA-Approved NTRK/ROS1 Inhibitor | GLT
Roche (China) original entrectinib — NMPA-approved, China's first ROS1/NTRK dual-target inhibitor for NSCLC and NTRK...
Sort
- Recommended
- Price: Low to High
- Price: High to Low
- Newest
- Best Selling